Scotiabank analyst Nicholas Yulico raised the firm’s price target on Healthcare Realty Trust to $16 from $15 and keeps a Sector Perform rating on the shares. The firm reviewed several key themes from the recent Q1 results and adjusted estimates, the analyst tells investors. U.S. REITS continue to screen historically cheap to the S&P 600, and the firm remains positive on Seniors Housing, Data Centers, and Industrial.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HR:
- Healthcare Realty Trust price target raised to $16 from $15 at Wedbush
- Healthcare Realty Trust Unveils Q1 Supplemental Information
- Healthcare Realty Trust sees FY24 normalized FFO $1.52-$1.58, consensus $1.56
- Healthcare Realty Trust sees Q2 normalized FFO 38c-39c
- Healthcare Realty Trust reports Q1 normalized FFO 39c, consensus 38c
Questions or Comments about the article? Write to editor@tipranks.com